價(jià)格 | ¥787 | ¥1490 | ¥2380 |
包裝 | 2mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-02-28 |
中文名稱(chēng):化合物 H-1152二鹽酸鹽 | 英文名稱(chēng):H-1152 dihydrochloride |
CAS:871543-07-6 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 98.42% | 產(chǎn)品類(lèi)別: 抑制劑 |
貨號(hào): T35328 |
名稱(chēng) | H-1152 dihydrochloride |
描述 | H-1152 dihydrochloride (H-1152 2HCl) is a specific inhibitor of Rho-associated protein kinase (ROCK) with an IC50 of 12 nM and a Ki of 1.6 nM. H-1152 dihydrochloride inhibits PKA, PKC, PKG, Aurora A and CaMKII with IC50 values of 3.03 μM, 5.68 μM, 0.360 μM, 0.745 μM and 0.180 μM, respectively. |
體外活性 | H-1152 dihydrochloride shows less inhibitory activities against Src, MLCK, Abl, EGFR, MKK4, GSK3α, AMPK, and P38α, with IC50s of 3.06, 28.3, 7.77, 50.0, 16.9, 60.7, 100, and 100 μM, respectively[1]. H-1152 dihydrochloride slightly suppresses PKA, PKC and MLCK, with Kis of?0.63, 9.27, and 10.1 μM, respectively. In LPA-treated cells, H-1152 dihydrochloride (0.1-10 μM) inhibits MARCKS phosphorylation (IC50 = 2.5 μM)[2]. H-1152 dihydrochloride (0.5-10 μM) does not decrease neuronal survival or alter the ratios of different neuronal morphologies. H-1152 dihydrochloride (10 μM) arguments neurite length in both BMP4 and LIF cultures[3]. |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 40 mg/mL (101.95 mM), Sonication is recommended. H2O : 32.1 mg/mL (81.9 mM ), Sonication is recommended. |
關(guān)鍵字 | H-1152 Dihydrochloride | H 1152 | H 1152 dihydrochloride | H1152 Dihydrochloride | H 1152 Dihydrochloride | H1152 dihydrochloride | H1152 | H-1152 |
相關(guān)產(chǎn)品 | Y-27632 dihydrochloride | CID-5056270 | ROCK-IN-5 | SB-747651A Dihydrochloride | Fasudil | Tofacitinib | CAY10746 | Y-27632 | RKI-1447 | SAR407899 hydrochloride | Thiazovivin | GSK180736A |
相關(guān)庫(kù) | 抑制劑庫(kù) | 經(jīng)典已知活性庫(kù) | 抗癌化合物庫(kù) | 已知活性化合物庫(kù) | 激酶抑制劑庫(kù) | 細(xì)胞骨架化合物庫(kù) | TGF-β/Smad靶點(diǎn)化合物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢(xún)價(jià) |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-04-09 | |
¥1800 |
VIP2年
|
湖北楚昌生物醫(yī)藥科技有限公司
|
2025-04-09 | |
詢(xún)價(jià) |
VIP9年
|
上海芮暉化工科技有限公司
|
2025-03-24 | |
¥399.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2025-02-27 |